Recently, Kaneko et al. (2022) demonstrated that as COVID-19 advances, cytotoxic CD4+ T lymphocytes (CD4 + CTLs) rise in the lungs, lymph nodes, and blood. This evidence concerns the gene CD4 and COVID-19.